top of page

Cancer
Digest

Curated cancer news and information

Olaparib may be sufficient for PSA recurrent prostate cancer among men with BRCA2 alterations

CANCER DIGEST – Aug. 24, 2024 – Men with mutations in a certain gene and whose prostate cancer is recurring as judged by a rising PSA,...

Olaparib may be sufficient for PSA recurrent prostate cancer among men with BRCA2 alterations

Recent Posts

Adding high-dose vitamin C doubled survival for late stage pancreatic cancer patients

Combination treatment shows promise for rare, fatal cancers

A diet rich in healthy fats may protect against cancer

Nanotechnology for prostate cancer treatment inches toward reality

Liver cancer recurrence higher for patients with diabetes and/or obesity

Newly approved myeloma treatment found highly effective in first real-world patient population

New drug proves effective in treating cancer-related wasting disease

Immunotherapy combination dramatically improves long-term survival for melanoma patients

Most early stage diagnoses of pancreatic cancer are inaccurate

Olaparib may be sufficient for PSA recurrent prostate cancer among men with BRCA2 alterations

bottom of page